Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma

Analytical Cellular Pathology

Volumn 33, Issue 5-6, 2010, Pages 207-216

  Zatelli, Maria Chiara ^a   Tagliati, Federico ^a   Amodio, Vincenzo ^a   Buratto, Mattia ^a   Pelizzo, Mariarosa ^b   Pansini, Giancarlo ^a   Bondanelli, Marta ^a   Ambrosio, Maria Rosaria ^a   Uberti, Ettore C Degli ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

medullary thyroid carcinoma; Pituitary tumour transforming gene 1; siRNA; TT cells

Indexed keywords

DNA; MESSENGER RNA; SECURIN; THYMIDINE; PITUITARY TUMOR TRANSFORMING PROTEINS; PITUITARY TUMOR-TRANSFORMING PROTEINS; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CELL HYPERPLASIA; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; LYMPH NODE METASTASIS; MALE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SAMPLE; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; TUMOR CELL; ADOLESCENT; BIOSYNTHESIS; FLUORESCENCE MICROSCOPY; GENETICS; HYPERPLASIA; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL PROLIFERATION; CHILD; FEMALE; GENE SILENCING; HUMANS; HYPERPLASIA; LYMPHATIC METASTASIS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955690917     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.3233/ACP-CLO-2010-0536     Document Type: Article

References (31)

1. K. Akino, S. Akita, T. Mizuguchi, I. Takumi, R. Yu, X.Y. Wang, J. Rozga, A.A. Demetriou, S. Melmed, A. Ohtsuru and S. Yamashita, A novel molecular marker of pituitary tumour transforming gene involves in a rat liver regeneration, Journal of Surgical Research 129 (2005), 142-146. (Pubitemid 41501867)
2. S.E. Artandi and R. DePinho, Telomeres and telomerase in cancer, Carcinogenesis 31 (2010), 9-18.
3. K. Boelaert, C.J. McCabe, L.A. Tannahill, N.J. Gittoes, R.L. Holder, J.C. Watkinson, A.R. Bradwell, M.C. Sheppard and J.A. Franklyn, Pituitary tumour transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer, Journal of Clinical Endocrinology and Metabolism 88 (2003), 2341-2347. (Pubitemid 36549916)
4. K. Boelaert, L.A. Tannahill, J.N. Bulmer, S. Kachilele, S.Y. Chan, D. Kim, N.J. Gittoes, J.A. Franklyn, M.D. Kilby and C.J. McCabe, A potential role for PTTG/securin in the developing human fetal brain, FASEB Journal 17 (2003), 1631-1639. (Pubitemid 37100064)
5. A. Cascon, A. Cebrian, M. Pollan, S. Ruiz-Llorente, C. Montero-Conde, R. Leton, R. Gutierrez, F. Lesueur, R.L. Milne, O. Gonzalez-Albarran, T. Lucas-Morante, J. Benitez, B.A. Ponder and M. Robledo, Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma, Journal of Clinical Endocrinology and Metabolism 90 (2005), 2127-2130. (Pubitemid 40586250)
6. E. Giorda, L. Sibilio, A. Martayan, G. Feriotto, N. Bianchi, C. Mischiati, F. Di Rosa, L. Pozzi, R. Gambari and P. Giacomini, Modular usage of the HLA-DRA promoter in extrahematopoietic and hematopoietic cell types of transgenic mice, FEBS Journal 272 (2005), 3214-3226. (Pubitemid 40904705)
7. A.P. Heaney, V. Nelson, M. Fernando and G. Horwitz, Transforming events in thyroid tumourigenesis and their association with follicular lesions, Journal of Clinical Endocrinology and Metabolism 86 (2001), 5025-5032. (Pubitemid 33020559)
8. H. Ishikawa, A.P. Heaney, R. Yu, G.A. Horwitz and S. Melmed, Human pituitary tumour-transforming gene induces angiogenesis, Journal of Clinical Endocrinology and Metabolism 86 (2001), 867-874. (Pubitemid 32207508)
9. S. Kakar and M.T. Malik, Suppression of lung cancer with siRNA targeting PTTG, International Journal of Oncology 29 (2006), 387-395.
10. D. Kim, H. Pemberton, A.L. Stratford, K. Boelaert, J.C. Watkinson, V. Lopes, J.A. Franklyn and C.J. McCabe, Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells, Oncogene 24 (2005), 4861-4866. (Pubitemid 41076304)
11. C.A. Koch, F.M. Brouwers, A.O. Vortmeyer, A. Tannapfel, S.K. Libutti, Z. Zhuang, K. Pacak, H.P. Neumann and R. Paschke, Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma, BMC Cancer 6 (2006), 131.
12. A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T.J. Van Vroonhoven, H.D. Roeher, R.A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx and H. Dralle, European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer, New England Journal of Medicine 349 (2003), 1517-1525. (Pubitemid 37255037)
13. C.J. McCabe, V. Boelaert, L.A. Tannahill, A.P. Heaney, A.L. Stratford, J.S. Khaira, S. Hussain, M.C. Sheppard, J.A. Franklyn and N.J. Gittoes, Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumour transforming gene in pituitary tumours, Journal of Clinical Endocrinology and Metabolism 87 (2002), 4238-4244.
14. L. Pei, Activation of mitogen-activated protein kinase cascade regulates pituitary tumour-transforming gene transactivation function, Journal of Biological Chemistry 275 (2000), 31191-31198.
15. L. Pei and S. Melmed, Isolation and characterization of a pituitary tumour-transforming gene (PTTG), Molecular Endocrinology 11 (1997), 433-441. (Pubitemid 27147011)
16. F. Romero, M.C. Multon, F. Ramos-Morales, A. Dominguez, J.A. Bernal, J.A. Pintor-Toro and M. Tortolero, Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase, Nucleic Acids Research 29 (2001), 1300-1307. (Pubitemid 32229457)
17. F. Salehi, K. Kovacs, B.W. Scheithauer, R.V. Lloyd and M. Cusimano, Pituitary tumour-transforming gene in endocrine and other neoplasms: a review and update, Endocrine Related Cancer 15 (2008), 721-743.
18. M. Santoro, R.M. Melillo, F. Carlomagno, R. Visconti, G. De Vita, G. Salvatore, G. Lupoli, A. Fusco and G. Vecchio, Molecular biology of the MEN2 gene, Journal of Internal Medicine 243 (1998), 505-508. (Pubitemid 28312248)
19. A.L. Stratford, K. Boelaert, L.A. Tannahill, D.S. Kim, A. Warfield, M.C. Eggo, N.J. Gittoes, L.S. Young, J.A. Franklyn and C.J. McCabe, Pituitary tumour transforming gene binding factor: a novel transforming gene in thy roid tumourigenesis, Journal of Clinical Endocrinology and Metabolism 90 (2005), 4341-4349. (Pubitemid 41058217)
20. F. Tagliati, M.C. Zatelli, A. Bottoni, D. Piccin, A. Luchin, M.D. Culler and E.C. degli Uberti, Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro, Endocrinology 147 (2006), 3530-3538. (Pubitemid 43901144)
21. Y. Tong, Y. Tan, C. Zhou and S. Melmed, Pituitary tumour transforming gene interacts with Sp1 to modulate G1/S cell phase transition, Oncogene 26 (2007), 5596-5605. (Pubitemid 47267833)
22. G. Vlotides, T. Eigler and S. Melmed, Pituitary tumourtransforming gene: physiology and implications for tumourigenesis, Endocrine Reviews 28 (2007), 165-186. (Pubitemid 46984833)
23. R. Yu, S.G. Ren, G.A. Horwitz, Z. Wang and S. Melmed, Pituitary tumour transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging, Molecular Endocrinology 14 (2000), 1137-1146. (Pubitemid 32260476)
24. M.C. Zatelli, F. Tagliati, J.E. Taylor, R. Rossi, M.D. Culler and E.C. degli Uberti, Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT, Journal of Clinical Endocrinology and Metabolism 86 (2001), 2161-2169. (Pubitemid 32472934)
25. M.C. Zatelli, F. Tagliati, D. Piccin, J.E. Taylor, M.D. Culler, M. Bondanelli and E.C. degli Uberti, Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line, Biochemical Biophysical Research Communications 297 (2002), 828-834.
26. M.C. Zatelli, F. Tagliati, J.E. Taylor, D. Piccin, M.D. Culler and E.C. degli Uberti, Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT, Hormone & Metabolic Research 34 (2002), 229-233. (Pubitemid 34666584)
27. M.C. Zatelli, D. Piccin, A. Bottoni, M.R. Ambrosio, A. Margutti, R. Padovani, M. Scanarini, J.E. Taylor, M.D. Culler, L. Cavazzini and E.C. degli Uberti, Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and Chromagranin A secretion and on cell viability in human non functioning pituitary adenomas in vitro, Journal of Clinical Endocrinology and Metabolism 89 (2004), 5181-5188. (Pubitemid 39391467)
28. M.C. Zatelli, D. Piccin, F. Tagliati, A. Bottoni, A. Luchin, C. Vignali, A. Margutti, M. Bondanelli, G.C. Pansini, M.R. Pelizzo, M.D. Culler and E.C. degli Uberti, Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives, Journal of Clinical Endocrinology and Metabolism 91 (2006), 2218-2224. (Pubitemid 43855009)
29. X. Zhang, G.A. Horwitz, A.P. Heaney, M. Nakashima, T.R. Prezant, M.D. Bronstein and S. Melmed, Structure, expression, and function of human pituitary tumour-transforming gene (PTTG), Molecular Endocrinology 13 (1999), 156-166. (Pubitemid 29022288)
30. H. Zou, T.J. McGarry, T. Bernal and M.W. Kirschner, Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumourigenesis, Science 285 (1999), 418-422.
31. A. Zur and M. Brandeis, Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis, EMBO Journal 20 (2001), 792-801. (Pubitemid 32167643)